Medicare utilization — DR. JAY B STALLMAN (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 20,580 | 60 | $0 | $597,133 |
| 92134 | Imaging of retina | 1,772 | 510 | $0 | $55,893 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,690 | 76 | $0 | $305,586 |
| 67028 | Injection of drug into eye | 1,401 | 238 | $0 | $126,234 |
| J0178 | Injection, aflibercept, 1 mg | 676 | 69 | $0 | $455,533 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·